Empagliflozin in Heart Failure with a Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

Published:2021-10-14 Issue:16 Volume:385 Page:1451-1461
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Anker Stefan D.¹,Butler Javed¹,Filippatos Gerasimos¹,Ferreira João P.¹,Bocchi Edimar¹,Böhm Michael¹,Brunner–La Rocca Hans-Peter¹,Choi Dong-Ju¹,Chopra Vijay¹,Chuquiure-Valenzuela Eduardo¹,Giannetti Nadia¹,Gomez-Mesa Juan Esteban¹,Janssens Stefan¹,Januzzi James L.¹,Gonzalez-Juanatey Jose R.¹,Merkely Bela¹,Nicholls Stephen J.¹,Perrone Sergio V.¹,Piña Ileana L.¹,Ponikowski Piotr¹,Senni Michele¹,Sim David¹,Spinar Jindrich¹,Squire Iain¹,Taddei Stefano¹,Tsutsui Hiroyuki¹,Verma Subodh¹,Vinereanu Dragos¹,Zhang Jian¹,Carson Peter¹,Lam Carolyn Su Ping¹,Marx Nikolaus¹,Zeller Cordula¹,Sattar Naveed¹,Jamal Waheed¹,Schnaidt Sven¹,Schnee Janet M.¹,Brueckmann Martina¹,Pocock Stuart J.¹,Zannad Faiez¹,Packer Milton¹^ORCID

Affiliation:

1. From the Department of Cardiology (CVK) and the Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Center for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.), Universitätsklinikum des Saarlandes, Homberg (M. Böhm), RWTH Aachen University, Aachen (N.M.), Boehringer Ingelheim Pharma, Biberach (C.Z., S.S.), Boehringer Ingelheim International, Ingelheim (W.J., M. Brueckmann), and the Faculty of Medicine Mannheim, University of...

Funder

Boehringer Ingelheim

Eli Lilly and Company

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2107038

Cited by 2662 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeat administration of human umbilical cord mesenchymal stem cells improves left ventricular diastolic function in mice with heart failure with preserved ejection fraction;Biochemical and Biophysical Research Communications;2024-12

2. Diagnostic and therapeutic practice for Heart Failure with preserved ejection fraction around the world: An international survey;Current Problems in Cardiology;2024-12

3. Rethinking diastolic function assessment in HFmrEF: Bridging the gap with advanced imaging and novel echocardiographic indices;International Journal of Cardiology;2024-12

4. Prognostic value of E/e’ ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era;Journal of Cardiology;2024-10

5. Dapagliflozin alleviates right heart failure by promoting collagen degradation by reducing ROS levels;European Journal of Pharmacology;2024-10